Dalan Animal Health Unlocks the Potential of Innate Immunity with its Vaccine Platform
Shots:
- Dalan Animal Health has developed shrimp vaccine for white spot syndrome virus (WSSV) & early mortality syndrome (EMS) using its innate immunity platform, extending its validation from honeybee vaccine to aquaculture
- Dalan’s shrimp vaccine (administered via the broodstock) will offer non-GMO as well as non-chemical alternative to conventional vaccines & has shown 62% & 61% absolute survival to WSSV & EMS, respectively
- Platform aims to provide broad-spectrum, lifetime prevention against new diseases across species, (incl. future potential in vertebrate) by utilizing once-considered non-specific, trainable potential of innate immunity
Ref: Prnewswire | Image: Dalan Animal Health
Related News:- Anivive Lifesciences Receives $20M Funding from Leonid Capital Partners to Develop Novel Programs for Pets
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
